DUBLIN, June 2, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Human Vaccine Market 2016-2020" report to their offering.

According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person's immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose.

Human vaccines are of two types: preventable human vaccines and therapeutic human vaccines. Preventable human vaccines are used both for adults and children. Pediatric human vaccines are used to immunize children against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.

The report forecasts the global human vaccines market to grow at a CAGR of 11.69% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global human vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of preventable and therapeutic human vaccines.

The market is divided into the following segments based on geography:

• Americas
• APAC
• Europe

The report, Global Human Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Companies Mentioned:

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• Abbott
• AstraZeneca
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• bioCSL
• Bio Med
• Crucell
• Dynavax Technologies
• Indian Immunologicals
• Janssen Pharmaceuticals
• Kaketsuken
• LG Life Sciences
• Mitsubishi Tanabe Pharma
• Lupin
• Nuron
• Novartis
• Protein Sciences Corporation
• Panacea Biotec
• Roche
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• S K Chemicals
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• Zydus Cadila

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Vaccine approval process

PART 06: Pipeline portfolio

PART 07: Market landscape

PART 08: Market segmentation by type of human vaccine

PART 09: Market segmentation by composition

PART 10: Market segmentation by route of administration

PART 11: Market segmentation by type of human vaccine

PART 12: Global therapeutic human vaccines market

PART 13: Global preventable human vaccines market

PART 14: Global pediatric preventable human vaccines market

PART 15: Global adult preventable human vaccines market

PART 16: Geographical segmentation

PART 17: Market drivers

PART 18: Impact of drivers

PART 19: Market challenges

PART 20: Impact of drivers and challenges

PART 21: Market trends

PART 22: Vendor landscape

PART 23: Key vendor analysis

PART 24: Appendix

PART 25: About the Author

For more information visit http://www.researchandmarkets.com/research/rj25h9/global_human

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets